BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8530448)

  • 1. Urokinase-type plasminogen activator-induced monocyte adhesion requires a carboxyl-terminal lysine and cAMP-dependent signal transduction.
    Li C; Liu JN; Gurewich V
    J Biol Chem; 1995 Dec; 270(51):30282-5. PubMed ID: 8530448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
    Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
    Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-type plasminogen activator-induced monocyte adhesion is modulated by kininogen, kallikrein, factor XII, and plasminogen.
    Li C; Gurewich V; Liu JN
    Exp Cell Res; 1996 Aug; 226(2):239-42. PubMed ID: 8806427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator up-regulates its own expression by endothelial cells and monocytes via the u-PAR pathway.
    Li C; Zhang J; Jiang Y; Gurewich V; Chen Y; Liu JN
    Thromb Res; 2001 Aug; 103(3):221-32. PubMed ID: 11672584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
    Moser TL; Enghild JJ; Pizzo SV; Stack MS
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.
    Del Rosso M; Anichini E; Pedersen N; Blasi F; Fibbi G; Pucci M; Ruggiero M
    Biochem Biophys Res Commun; 1993 Jan; 190(2):347-52. PubMed ID: 8381273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor.
    Koopman JL; Slomp J; de Bart AC; Quax PH; Verheijen JH
    J Biol Chem; 1998 Dec; 273(50):33267-72. PubMed ID: 9837898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclic AMP on urokinase-type plasminogen activator receptor and fibrinolytic factors in a human osteoblast-like cell line.
    Nonaka T; Matsumoto H; Shimada W; Miyagi I; Okada K; Fukao H; Ueshima S; Kikuchi H; Tanaka S; Matsuo O
    Biochim Biophys Acta; 1995 Apr; 1266(1):50-6. PubMed ID: 7718621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
    Rabbani SA; Mazar AP; Bernier SM; Haq M; Bolivar I; Henkin J; Goltzman D
    J Biol Chem; 1992 Jul; 267(20):14151-6. PubMed ID: 1321137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
    Stoppelli MP; Corti A; Soffientini A; Cassani G; Blasi F; Assoian RK
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4939-43. PubMed ID: 2991901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
    Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
    Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.
    Nielsen LS; Kellerman GM; Behrendt N; Picone R; Danø K; Blasi F
    J Biol Chem; 1988 Feb; 263(5):2358-63. PubMed ID: 2828365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells.
    Del Rosso M; Pedersen N; Fibbi G; Pucci M; Dini G; Anichini E; Blasi F
    Exp Cell Res; 1992 Dec; 203(2):427-34. PubMed ID: 1333982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters.
    Anichini E; Zamperini A; Chevanne M; Caldini R; Pucci M; Fibbi G; Del Rosso M
    Biochemistry; 1997 Mar; 36(11):3076-83. PubMed ID: 9115983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
    Mirshahi SS; Lounes KC; Lu H; Pujade-Lauraine E; Mishal Z; Bénard J; Bernadou A; Soria C; Soria J
    FEBS Lett; 1997 Jul; 411(2-3):322-6. PubMed ID: 9271229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
    Reuning U; Bang NU
    Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
    Kanse SM; Kost C; Wilhelm OG; Andreasen PA; Preissner KT
    Exp Cell Res; 1996 May; 224(2):344-53. PubMed ID: 8612711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor binding and degradation of urokinase-type plasminogen activator by human mesangial cells.
    Nguyen G; Li XM; Peraldi MN; Zacharias U; Hagège J; Rondeau E; Sraer JD
    Kidney Int; 1994 Jul; 46(1):208-15. PubMed ID: 7933839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway.
    Syrovets T; Tippler B; Rieks M; Simmet T
    Blood; 1997 Jun; 89(12):4574-83. PubMed ID: 9192782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of u-PA and u-PAR on monocytes by LDL and Lp(a) lipoproteins--consequences for plasmin generation and monocyte adhesion.
    Ganné F; Vasse M; Beaudeux JL; Peynet J; François A; Paysant J; Lenormand B; Collet JP; Vannier JP; Soria J; Soria C
    Thromb Haemost; 1999 Apr; 81(4):594-600. PubMed ID: 10235446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.